Mastalerz Kinga, Kenig Jakub, Olszewska Urszula, Michalik Cyprian
Department of General, Oncologic and Geriatric Surgery, Jagiellonian University Medical College, Krakow, Poland.
Department of Urology, Ludwik Rydygier Memorial Specialized Hospital, Krakow, Poland.
Wideochir Inne Tech Maloinwazyjne. 2018 Sep;13(3):350-357. doi: 10.5114/wiitm.2018.75878. Epub 2018 May 21.
Frailty increases the risk of poor surgical outcomes in the older population. Some intraoperative factors may also influence the final result and can be evaluated. The Surgical Apgar Score (SAS) is a simple system predicting postoperative mortality and morbidity. However, the utility of the SAS remains unknown in fit and frail older patients undergoing elective laparoscopic cholecystectomy due to benign gallbladder diseases.
To evaluate the usefulness of the SAS in predicting 30-day morbidity and 1-year mortality in older fit and frail patients undergoing elective laparoscopic cholecystectomy.
Consecutive patients (≥ 70 years) were enrolled in the prospective study. The Comprehensive Geriatric Assessment (CGA) was used to diagnose frailty. Logistic regression was conducted to investigate the association between the scores and the outcomes.
The study included 144 consecutive older patients with a median age of 76 (range: 70-91) years. The prevalence of frailty was 44.4%. The 30-day mortality and morbidity were 0% and 11.8%, respectively. The 1-year mortality was 6.3% and 7 out of 9 occurred in the frail group. SAS < 7 points was identified as an independent predictor of 30-day postoperative morbidity (OR = 5.1; 95% CI: 1.5-18.1). Age > 85 years (OR = 1.9; 95% CI: 1.2-16.4) and frailty (OR = 3.4; 95% CI: 1.1-19.3) were predictors of 1-year mortality.
Laparoscopic cholecystectomy can be safely performed in older fit and frail patients. The SAS, not age, turned out to be the most important predictor of 30-day morbidity. Frailty and age > 85 years were predictors of 1-year mortality. Older patients with SAS < 7 points should be followed meticulously in order to diagnose and treat potential complications early on.
衰弱会增加老年人群手术预后不良的风险。一些术中因素也可能影响最终结果且可被评估。外科阿普加评分(SAS)是一个预测术后死亡率和发病率的简单系统。然而,对于因良性胆囊疾病接受择期腹腔镜胆囊切除术的健康和衰弱老年患者,SAS的效用仍不明确。
评估SAS在预测因良性胆囊疾病接受择期腹腔镜胆囊切除术的健康和衰弱老年患者30天发病率和1年死亡率方面的效用。
连续纳入(≥70岁)患者进行前瞻性研究。采用综合老年评估(CGA)诊断衰弱。进行逻辑回归以研究评分与结局之间的关联。
该研究纳入了144例连续的老年患者,中位年龄为76岁(范围:70 - 91岁)。衰弱患病率为44.4%。30天死亡率和发病率分别为0%和11.8%。1年死亡率为6.3%,9例中有7例发生在衰弱组。SAS < 7分被确定为术后30天发病率的独立预测因素(OR = 5.1;95% CI:1.5 - 18.1)。年龄> 85岁(OR = 1.9;95% CI:1.2 - 16.4)和衰弱(OR = 3.4;95% CI:1.1 - 19.3)是1年死亡率的预测因素。
健康和衰弱的老年患者均可安全地进行腹腔镜胆囊切除术。SAS而非年龄是30天发病率的最重要预测因素。衰弱和年龄> 85岁是1年死亡率的预测因素。对于SAS < 7分的老年患者应密切随访,以便早期诊断和治疗潜在并发症。